iTonic Holdings Ltd.
$0.32
▼
-7.43%
2026-04-21 07:36:01
www.ftzy.com.cn
NCM: ITOC
Explore iTonic Holdings Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$5.41 M
Current Price
$0.32
52W High / Low
$32 / $0.25
Stock P/E
—
Book Value
$0.36
Dividend Yield
—
ROCE
-59.82%
ROE
-71.25%
Face Value
—
EPS
$-0.32
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
7
Beta
—
Debt / Equity
1.76
Current Ratio
8.83
Quick Ratio
8.72
Forward P/E
—
Price / Sales
13.23
Enterprise Value
$3.99 M
EV / EBITDA
-0.77
EV / Revenue
7.64
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Bio-Rad Laboratories, Inc. | NOT FOUND | — | — | — | 2.17% | 10.84% | $343.12 / $211.43 | $276.16 |
| 2. | Bio-Rad Laboratories, Inc. | $302.22 | 10.88 | $8.04 B | — | 2.17% | 10.84% | $343.12 / $211.43 | $276.16 |
| 3. | CeriBell, Inc. | $21.13 | — | $797.62 M | — | -33.07% | -30.83% | $24.33 / $10.85 | $4.14 |
| 4. | TransMedics Group, Inc. | $113.13 | 20.39 | $3.88 B | — | 11.09% | 54.24% | $156 / $84.53 | $13.81 |
| 5. | Pulmonx Corporation | $1.42 | — | $59.98 M | — | -49.13% | -77.19% | $5.46 / $1.13 | $1.3 |
| 6. | Catheter Precision, Inc. | $0.97 | — | $2.63 M | — | -43.77% | -1.92% | $15.68 / $0.79 | $2.62 |
| 7. | Phaos Technology Holdings (Caym | $1.95 | — | — | — | 214.51% | -10.73% | $7.39 / $0.53 | $-0.06 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0.52 M | 0.45 M | 0.63 M | 0.68 M |
| Operating Profit | -5.16 M | -0.66 M | -0.26 M | 0.07 M |
| Net Profit | -5.1 M | -0.66 M | -0.24 M | 0.08 M |
| EPS in Rs | -0.54 | -0.07 | -0.03 | 0.01 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 9.1 M | 6.72 M | 1.62 M | 1.4 M |
| Total Liabilities | 0.97 M | 0.54 M | 1.31 M | 0.85 M |
| Equity | 6.12 M | 6.18 M | 0.31 M | 0.56 M |
| Current Assets | 4.09 M | 6.68 M | 0.53 M | 0.72 M |
| Current Liabilities | 0.46 M | 0.54 M | 1.21 M | 0.68 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -3.23 M | -0.78 M | -0.06 M | -0.12 M |
| Investing CF | -1.35 M | -0 M | 0 M | 0 M |
| Financing CF | -0.09 M | 6.71 M | 0.22 M | 0.08 M |
| Free CF | -3.24 M | -0.78 M | -0.06 M | -0.12 M |
| Capex | -0 M | -0 M | — | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -28.7% | -7.53% | — | — |
| Earnings Growth % | -173.86% | -387.23% | — | — |
| Profit Margin % | -147.39% | -38.37% | 12.35% | — |
| Operating Margin % | -147.69% | -41.13% | 10.96% | — |
| Gross Margin % | 85.04% | 74.9% | 82.11% | — |
| EBITDA Margin % | -131.53% | -31.08% | 18.92% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.